	title	date	publication	URL	Covid19-review_paperLink	gh_issue_link	gh_issue_labels	doi
0	Fields virology	2007			https://greenelab.github.io/covid19-review/#ref-RGAUx68v			
1	Introduction to modern virology	2007			https://greenelab.github.io/covid19-review/#ref-14gthSuhm			
2	Cancer-related issues of CD147.		Cancer genomics & proteomics	https://www.ncbi.nlm.nih.gov/pubmed/20551248	https://greenelab.github.io/covid19-review/#ref-ETkyotLv			
3	Interleukin-6 is the central tumor growth factor in vitro and in vivo in multiple myeloma.		European cytokine network	https://www.ncbi.nlm.nih.gov/pubmed/2104241	https://greenelab.github.io/covid19-review/#ref-glBmWODR			
4	The effects of hybridoma growth factor in conditioned media upon the growth, cloning, and antibody production of heterohybridoma cell lines.	1-1993	Human antibodies and hybridomas	https://www.ncbi.nlm.nih.gov/pubmed/8431556	https://greenelab.github.io/covid19-review/#ref-J7evEkJG			
5	Mild/Moderate 2019-nCoV Remdesivir RCT - Full Text View - ClinicalTrials.gov			https://clinicaltrials.gov/ct2/show/NCT04252664	https://greenelab.github.io/covid19-review/#ref-DvAlA1ad			
6	Severe 2019-nCoV Remdesivir RCT - Full Text View - ClinicalTrials.gov			https://clinicaltrials.gov/ct2/show/NCT04257656	https://greenelab.github.io/covid19-review/#ref-1CJoAQiUA			
7	Adaptive COVID-19 Treatment Trial (ACTT) - Full Text View - ClinicalTrials.gov			https://clinicaltrials.gov/ct2/show/NCT04280705	https://greenelab.github.io/covid19-review/#ref-19tnPvv1p			
8	Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment - Full Text View - ClinicalTrials.gov			https://clinicaltrials.gov/ct2/show/NCT04292730	https://greenelab.github.io/covid19-review/#ref-8a4WEEFh			
9	Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19) - Full Text View - ClinicalTrials.gov			https://clinicaltrials.gov/ct2/show/NCT04292899	https://greenelab.github.io/covid19-review/#ref-7LMnOrzx			
10	Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers - Full Text View - ClinicalTrials.gov			https://clinicaltrials.gov/ct2/show/NCT04336410	https://greenelab.github.io/covid19-review/#ref-HNx8txpX			
11				https://doi.org/10.1101/2020.01.27.20018952	https://greenelab.github.io/covid19-review/#ref-uTI5OuZt			
12	<i>Coronaviridae</i>	4-9-2020	Wikipedia	https://en.wikipedia.org/w/index.php?title=Coronaviridae&oldid=949957081	https://greenelab.github.io/covid19-review/#ref-YLbd18g5			
13	Potential roles of social distancing in mitigating the spread of coronavirus disease 2019 (COVID-19) in South Korea	2020	GitHub	https://github.com/parksw3/Korea-analysis/blob/master/v1/korea.pdf	https://greenelab.github.io/covid19-review/#ref-YfOcGRRa			
14	Coronaviridae ~ ViralZone page			https://viralzone.expasy.org/30?outline	https://greenelab.github.io/covid19-review/#ref-ZUuGRxk9			
15	Coronavirus Disease 2019 (COVID-19)	2-11-2020	Centers for Disease Control and Prevention	https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html	https://greenelab.github.io/covid19-review/#ref-vEFSIErd			
16				https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-000936-23/FR	https://greenelab.github.io/covid19-review/#ref-1q4PmqTm			
17		4-7-2020		https://www.fda.gov/media/136625/download	https://greenelab.github.io/covid19-review/#ref-n6sKSpIk			
18	Coronavirus Update: FDA and FTC Warn Seven Companies Selling Fraudulent Products that Claim to Treat or Prevent COVID-19	3-27-2020	FDA	https://www.fda.gov/news-events/press-announcements/coronavirus-update-fda-and-ftc-warn-seven-companies-selling-fraudulent-products-claim-treat-or	https://greenelab.github.io/covid19-review/#ref-fez8aZAu			
19	Genentech Launches Phase III Trial of Actemra as Coronavirus Treatment	3-19-2020	GEN - Genetic Engineering and Biotechnology News	https://www.genengnews.com/virology/coronavirus/genentech-launches-phase-iii-trial-of-actemra-as-coronavirus-treatment/	https://greenelab.github.io/covid19-review/#ref-JgXCBFEo			
20	Statement on IJAA paper | International Society of Antimicrobial Chemotherapy			https://www.isac.world/news-and-publications/official-isac-statement	https://greenelab.github.io/covid19-review/#ref-10J3hBiMo			
21	BCG vaccination to Reduce the impact of COVID-19 in Australian healthcare workers following Coronavirus Exposure (BRACE) Trial | Murdoch Children's Research Institute			https://www.mcri.edu.au/BRACE	https://greenelab.github.io/covid19-review/#ref-MCuIRGFE			
22	Optimal Nutritional Status for a Well-Functioning Immune System is an Important Factor to Protect Against Viral Infections	3-12-2020		https://www.preprints.org/manuscript/202003.0199/v1	https://greenelab.github.io/covid19-review/#ref-1EaIsb9L2			
23	Newer Vaccine Technologies Deployed to Develop COVID-19 Shot		The Scientist Magazine®	https://www.the-scientist.com/news-opinion/newer-vaccine-technologies-deployed-to-develop-covid-19-shot-67152	https://greenelab.github.io/covid19-review/#ref-wPl93ATP			
24	COVID-19 – Italy launches an independent trial on tocilizumab		COVID-19 – Italy launches an independent trial on tocilizumab | Univadis	https://www.univadis.co.uk/viewarticle/covid-19-italy-launches-an-independent-trial-on-tocilizumab-715741	https://greenelab.github.io/covid19-review/#ref-123fXWICW			
25	WHO | DNA vaccines		WHO	https://www.who.int/biologicals/areas/vaccines/dna/en/	https://greenelab.github.io/covid19-review/#ref-XnrBoKVk			
26		1-27-2020		https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200121-sitrep-1-2019-ncov.pdf	https://greenelab.github.io/covid19-review/#ref-Vb5KFWnO			
27		1-28-2020		https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200128-sitrep-8-ncov-cleared.pdf	https://greenelab.github.io/covid19-review/#ref-fLTiwToY			
28		3-11-2020		https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200311-sitrep-51-covid-19.pdf	https://greenelab.github.io/covid19-review/#ref-x9975iBK			
29		4-5-2020		https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200404-sitrep-75-covid-19.pdf?sfvrsn	https://greenelab.github.io/covid19-review/#ref-12u4h9N8z			
30						https://github.com/greenelab/covid19-review/issues/109	New Paper, Review Needed, biostatistics, epidemiology	
31						https://github.com/greenelab/covid19-review/issues/99	New Paper, Review Needed, pharmacology, therapeutic	
32						https://github.com/greenelab/covid19-review/issues/74	New Paper, Review Needed, pharmacology, therapeutic	
33	Effect of Vitamin C Infusion on Organ Failure and Biomarkers of Inflammation and Vascular Injury in Patients With Sepsis and Severe Acute Respiratory Failure	10-1-2019	JAMA	https://doi.org/ggqmh8	https://greenelab.github.io/covid19-review/#ref-Rt5Aik4p			10.1001/jama.2019.11825
34	Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China	2-7-2020	JAMA	https://doi.org/ggkh48	https://greenelab.github.io/covid19-review/#ref-VRoblZFJ			10.1001/jama.2020.1585
35	Vitamin C for preventing and treating the common cold	1-31-2013	Cochrane Database of Systematic Reviews	https://doi.org/xz5	https://greenelab.github.io/covid19-review/#ref-Pb5PCH7y			10.1002/14651858.cd000980.pub4
36	Emerging coronaviruses: Genome structure, replication, and pathogenesis	2-7-2020	Journal of Medical Virology	https://doi.org/ggjvwj	https://greenelab.github.io/covid19-review/#ref-18GflyMj			10.1002/jmv.25681
37	Potential interventions for novel coronavirus in China: A systematic review	3-3-2020	Journal of Medical Virology	https://doi.org/ggpx57	https://greenelab.github.io/covid19-review/#ref-2hMFPQJR			10.1002/jmv.25707
38	The potential chemical structure of anti‐SARS‐CoV‐2 RNA‐dependent RNA polymerase	3-13-2020	Journal of Medical Virology	https://doi.org/ggp6fm	https://greenelab.github.io/covid19-review/#ref-Sh1FwWps			10.1002/jmv.25761
39	Detection of antibodies against SARS-CoV-2 in patients with COVID-19	4-10-2020	Journal of Medical Virology	https://doi.org/ggq7m2	https://greenelab.github.io/covid19-review/#ref-FFMfMDRN			10.1002/jmv.25820
40	Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis	6-2004	The Journal of Pathology	https://doi.org/bhpzc3	https://greenelab.github.io/covid19-review/#ref-1FE1YGsaV			10.1002/path.1570
41	Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2 <sup>+</sup> cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS	11-2006	The Journal of Pathology	https://doi.org/bwb8ns	https://greenelab.github.io/covid19-review/#ref-NNFGje9g			10.1002/path.2067
42	Differential expression of serum/plasma proteins in various infectious diseases: Specific or nonspecific signatures	2-2014	PROTEOMICS - Clinical Applications	https://doi.org/f2px3h	https://greenelab.github.io/covid19-review/#ref-8vUHj9cm			10.1002/prca.201300074
43	Coronaviruses	2015	Methods in Molecular Biology	https://doi.org/ggqfqx	https://greenelab.github.io/covid19-review/#ref-tn6j6IZ0			10.1007/978-1-4939-2438-7
44	Coronaviruses: An Overview of Their Replication and Pathogenesis	2015	Methods in Molecular Biology	https://doi.org/ggpc6n	https://greenelab.github.io/covid19-review/#ref-47hnjvDb			10.1007/978-1-4939-2438-7_1
45	Intravenous infusion of ascorbic acid decreases serum histamine concentrations in patients with allergic and non-allergic diseases	5-11-2013	Naunyn-Schmiedeberg's Archives of Pharmacology	https://doi.org/f48jsb	https://greenelab.github.io/covid19-review/#ref-RjFxOURM			10.1007/s00210-013-0880-1
46	Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology	5-2-2017	Seminars in Immunopathology	https://doi.org/ggqf2w	https://greenelab.github.io/covid19-review/#ref-suIFBW			10.1007/s00281-017-0629-x
47	Metabolism of ascorbic acid (vitamin C) in subjects infected with common cold viruses	2-1979	Biochemical Medicine	https://doi.org/fd22sv	https://greenelab.github.io/covid19-review/#ref-1Bj8VMlSk			10.1016/0006-2944(79)90058-9
48	Zinc and immunity: An essential interrelation	12-2016	Archives of Biochemistry and Biophysics	https://doi.org/f9c9b5	https://greenelab.github.io/covid19-review/#ref-VMI1lOFR			10.1016/j.abb.2016.03.022
49	Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model	5-2014	Antiviral Research	https://doi.org/f524m3	https://greenelab.github.io/covid19-review/#ref-gY3NNmLM			10.1016/j.antiviral.2014.02.014
50	The SARS-coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compounds	3-2015	Antiviral Research	https://doi.org/f63hjp	https://greenelab.github.io/covid19-review/#ref-NB1udFHF			10.1016/j.antiviral.2014.12.015
51	14th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends	6-2014	Autoimmunity Reviews	https://doi.org/ggp8r8	https://greenelab.github.io/covid19-review/#ref-rL8owM5Y			10.1016/j.autrev.2014.01.053
52	Analysis of multimerization of the SARS coronavirus nucleocapsid protein	4-2004	Biochemical and Biophysical Research Communications	https://doi.org/dbfwr9	https://greenelab.github.io/covid19-review/#ref-JLTf2Fwb			10.1016/j.bbrc.2004.02.074
53	Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis	6-2020	Clinica Chimica Acta	https://doi.org/ggpxp7	https://greenelab.github.io/covid19-review/#ref-K9G9QT8y			10.1016/j.cca.2020.03.004
54	The Lipid Mediator Protectin D1 Inhibits Influenza Virus Replication and Improves Severe Influenza	3-2013	Cell	https://doi.org/f4rbgb	https://greenelab.github.io/covid19-review/#ref-fIo3ESPM			10.1016/j.cell.2013.02.027
55	Development and Applications of CRISPR-Cas9 for Genome Engineering	6-2014	Cell	https://doi.org/f6d3wg	https://greenelab.github.io/covid19-review/#ref-1272qWb3a			10.1016/j.cell.2014.05.010
56	Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion	2-2019	Cell	https://doi.org/gft3jg	https://greenelab.github.io/covid19-review/#ref-Ftbm1M9p			10.1016/j.cell.2018.12.028
57	SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor	3-2020	Cell	https://doi.org/ggnq74	https://greenelab.github.io/covid19-review/#ref-15l3di3Wj			10.1016/j.cell.2020.02.052
58	Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein	3-2020	Cell	https://doi.org/dpvh	https://greenelab.github.io/covid19-review/#ref-qcVbT0w4	https://github.com/greenelab/covid19-review/issues/156	New Paper, Review Needed, immunology, virology	10.1016/j.cell.2020.02.058
59	Non-specific effects of BCG vaccine on viral infections	12-2019	Clinical Microbiology and Infection	https://doi.org/ggq62z	https://greenelab.github.io/covid19-review/#ref-16FOT89K5			10.1016/j.cmi.2019.04.020
60	Electroporation delivery of DNA vaccines: prospects for success	6-2011	Current Opinion in Immunology	https://doi.org/cq8b4p	https://greenelab.github.io/covid19-review/#ref-H6tWVs5R			10.1016/j.coi.2011.03.008
61	Vitamin D: modulator of the immune system	8-2010	Current Opinion in Pharmacology	https://doi.org/d43qtf	https://greenelab.github.io/covid19-review/#ref-nwEQBjV4			10.1016/j.coph.2010.04.001
62	Plasticity and cross-talk of Interleukin 6-type cytokines	6-2012	Cytokine & Growth Factor Reviews	https://doi.org/f3z743	https://greenelab.github.io/covid19-review/#ref-1BxkPZYnj			10.1016/j.cytogfr.2012.04.001
63	TEMPORARY REMOVAL: Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study	3-2020	Engineering	https://doi.org/ggpprd	https://greenelab.github.io/covid19-review/#ref-13Oz7yRPx			10.1016/j.eng.2020.03.007
64	Systems Approaches to Biology and Disease Enable Translational Systems Medicine	8-2012	Genomics, Proteomics & Bioinformatics	https://doi.org/f4f599	https://greenelab.github.io/covid19-review/#ref-5MhhHQO0			10.1016/j.gpb.2012.08.004
65	Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial	3-2020	International Journal of Antimicrobial Agents	https://doi.org/dp7d	https://greenelab.github.io/covid19-review/#ref-ovHLMvCi	https://github.com/greenelab/covid19-review/issues/93	Additional Reviews Welcome, New Paper, therapeutic, virology	10.1016/j.ijantimicag.2020.105949
66	Estimation of the reproductive number of novel coronavirus (COVID-19) and the probable outbreak size on the Diamond Princess cruise ship: A data-driven analysis	4-2020	International Journal of Infectious Diseases	https://doi.org/ggpx56	https://greenelab.github.io/covid19-review/#ref-10bBqMHH7			10.1016/j.ijid.2020.02.033
67	Chloroquine: Modes of action of an undervalued drug	6-2013	Immunology Letters	https://doi.org/f5b5cr	https://greenelab.github.io/covid19-review/#ref-BIlqPh6M			10.1016/j.imlet.2013.07.004
68	Proresolving Lipid Mediators and Mechanisms in the Resolution of Acute Inflammation	3-2014	Immunity	https://doi.org/f5wntr	https://greenelab.github.io/covid19-review/#ref-BIVORG2X			10.1016/j.immuni.2014.02.009
69	The antiviral effect of interferon-beta against SARS-Coronavirus is not mediated by MxA protein	7-2004	Journal of Clinical Virology	https://doi.org/cmc3ds	https://greenelab.github.io/covid19-review/#ref-LtFtUo2P			10.1016/j.jcv.2003.11.013
70	Modulation of host defence against bacterial and viral infections by omega-3 polyunsaturated fatty acids	12-2016	Journal of Infection	https://doi.org/f9pp2h	https://greenelab.github.io/covid19-review/#ref-3Xht24k3			10.1016/j.jinf.2016.10.001
71	Vitamin D in the prevention of acute respiratory infection: Systematic review of clinical studies	7-2013	The Journal of Steroid Biochemistry and Molecular Biology	https://doi.org/ggqmh9	https://greenelab.github.io/covid19-review/#ref-iWLsflrG			10.1016/j.jsbmb.2012.11.017
72	No Evidence of Rapid Antiviral Clearance or Clinical Benefit with the Combination of Hydroxychloroquine and Azithromycin in Patients with Severe COVID-19 Infection	3-2020	Médecine et Maladies Infectieuses	https://doi.org/ggqzrb	https://greenelab.github.io/covid19-review/#ref-18KmvBOFr			10.1016/j.medmal.2020.03.006
73	Broadly Neutralizing Antibodies against HIV: Back to Blood	3-2019	Trends in Molecular Medicine	https://doi.org/ggqbpr	https://greenelab.github.io/covid19-review/#ref-oGHFF5Cm			10.1016/j.molmed.2019.01.007
74	Nutraceuticals have potential for boosting the type 1 interferon response to RNA viruses including influenza and coronavirus	2-2020	Progress in Cardiovascular Diseases	https://doi.org/ggpwx2	https://greenelab.github.io/covid19-review/#ref-eyBAUUCl	https://github.com/greenelab/covid19-review/issues/70	New Paper, Review Needed, therapeutic, virology	10.1016/j.pcad.2020.02.007
75	Up-regulation of IL-6 and TNF-α induced by SARS-coronavirus spike protein in murine macrophages via NF-κB pathway	9-2007	Virus Research	https://doi.org/bm7m55	https://greenelab.github.io/covid19-review/#ref-QkTGQUcj			10.1016/j.virusres.2007.02.007
76	Coronavirus virulence genes with main focus on SARS-CoV envelope gene	12-2014	Virus Research	https://doi.org/f6wm24	https://greenelab.github.io/covid19-review/#ref-Nfu9kiae			10.1016/j.virusres.2014.07.024
77	The roles of CyPA and CD147 in cardiac remodelling	6-2018	Experimental and Molecular Pathology	https://doi.org/ggq622	https://greenelab.github.io/covid19-review/#ref-34nQJalJ			10.1016/j.yexmp.2018.05.001
78	A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster	2-2020	The Lancet	https://doi.org/ggjs7j	https://greenelab.github.io/covid19-review/#ref-IFLf8rsY			10.1016/s0140-6736(20)30154-9
79	Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China	2-2020	The Lancet	https://doi.org/ggjfnn	https://greenelab.github.io/covid19-review/#ref-vasHgjGH			10.1016/s0140-6736(20)30183-5
80	Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding	2-2020	The Lancet	https://doi.org/ggjr43	https://greenelab.github.io/covid19-review/#ref-1Fqilxaum			10.1016/s0140-6736(20)30251-8
81	Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study	1-2020	The Lancet	https://doi.org/ggjvr7	https://greenelab.github.io/covid19-review/#ref-1E0r4uZy9			10.1016/s0140-6736(20)30260-9
82	Reducing mortality from 2019-nCoV: host-directed therapies should be an option	2-2020	The Lancet	https://doi.org/ggkd3b	https://greenelab.github.io/covid19-review/#ref-GT7yDBjv			10.1016/s0140-6736(20)30305-6
83	Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study	3-2020	The Lancet	https://doi.org/ggnxb3	https://greenelab.github.io/covid19-review/#ref-10THxyeCg			10.1016/s0140-6736(20)30566-3
84	The Role of ACE2 in Cardiovascular Physiology	4-2003	Trends in Cardiovascular Medicine	https://doi.org/bsbp49	https://greenelab.github.io/covid19-review/#ref-1GLr0EJU			10.1016/s1050-1738(02)00233-5
85	New insights into the antiviral effects of chloroquine	2-2006	The Lancet Infectious Diseases	https://doi.org/dh8phb	https://greenelab.github.io/covid19-review/#ref-8Vf8rD2W			10.1016/s1473-3099(06)70361-9
86	Early dynamics of transmission and control of COVID-19: a mathematical modelling study	3-2020	The Lancet Infectious Diseases	https://doi.org/ggptcf	https://greenelab.github.io/covid19-review/#ref-tiRfUgvs	https://github.com/greenelab/covid19-review/issues/69	New Paper, Review Needed, biostatistics, epidemiology	10.1016/s1473-3099(20)30144-4
87	Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study	3-2020	The Lancet Infectious Diseases	https://doi.org/ggp4qx	https://greenelab.github.io/covid19-review/#ref-fCZXxoas			10.1016/s1473-3099(20)30196-1
88	The COVID-19 vaccine development landscape	4-9-2020	Nature Reviews Drug Discovery	https://doi.org/ggrnbr	https://greenelab.github.io/covid19-review/#ref-1GA95MF2m			10.1038/d41573-020-00073-5
89	Coronavirus and the race to distribute reliable diagnostics	2-19-2020	Nature Biotechnology	https://doi.org/ggm4nt	https://greenelab.github.io/covid19-review/#ref-Fdc7seLs			10.1038/d41587-020-00002-2
90	Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus	11-2003	Nature	https://doi.org/bqvpjh	https://greenelab.github.io/covid19-review/#ref-2QTH37Xi			10.1038/nature02145
91	Basigin is a receptor essential for erythrocyte invasion by Plasmodium falciparum	11-9-2011	Nature	https://doi.org/dm59hf	https://greenelab.github.io/covid19-review/#ref-YcyNaIVC			10.1038/nature10606
92	Nutraceutical therapies for atherosclerosis	7-7-2016	Nature Reviews Cardiology	https://doi.org/f9g389	https://greenelab.github.io/covid19-review/#ref-2Us0gNMr			10.1038/nrcardio.2016.103
93	Specialized pro-resolving mediators: endogenous regulators of infection and inflammation	12-21-2015	Nature Reviews Immunology	https://doi.org/f9fgtd	https://greenelab.github.io/covid19-review/#ref-uPOTvvjR			10.1038/nri.2015.4
94	SARS and MERS: recent insights into emerging coronaviruses	6-27-2016	Nature Reviews Microbiology	https://doi.org/f8v5cv	https://greenelab.github.io/covid19-review/#ref-G5NJrE75	https://github.com/greenelab/covid19-review/issues/54	New Paper, Review Needed, immunology, virology	10.1038/nrmicro.2016.81
95	Transmission routes of 2019-nCoV and controls in dental practice	3-3-2020	International Journal of Oral Science	https://doi.org/ggnf47	https://greenelab.github.io/covid19-review/#ref-vP6yTZ0y			10.1038/s41368-020-0075-9
96	Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro	2-4-2020	Cell Research	https://doi.org/ggkbsg	https://greenelab.github.io/covid19-review/#ref-IhdcvbzC	https://github.com/greenelab/covid19-review/issues/138	New Paper, Review Needed, therapeutic	10.1038/s41422-020-0282-0
97	A systems approach to infectious disease	2-14-2020	Nature Reviews Genetics	https://doi.org/ggnv63	https://greenelab.github.io/covid19-review/#ref-8esIIWt9			10.1038/s41576-020-0212-5
98	Origin and evolution of pathogenic coronaviruses	12-10-2018	Nature Reviews Microbiology	https://doi.org/ggh4vb	https://greenelab.github.io/covid19-review/#ref-UBTUyMGV			10.1038/s41579-018-0118-9
99	A new coronavirus associated with human respiratory disease in China	2-3-2020	Nature	https://doi.org/dk2w	https://greenelab.github.io/covid19-review/#ref-vHq0hOWQ			10.1038/s41586-020-2008-3
100	A pneumonia outbreak associated with a new coronavirus of probable bat origin	2-3-2020	Nature	https://doi.org/ggj5cg	https://greenelab.github.io/covid19-review/#ref-VSkK7CeP	https://github.com/greenelab/covid19-review/issues/165	New Paper, Review Needed, virology	10.1038/s41586-020-2012-7
101	The proximal origin of SARS-CoV-2	3-17-2020	Nature Medicine	https://doi.org/ggn4dn	https://greenelab.github.io/covid19-review/#ref-NEIoHDjq			10.1038/s41591-020-0820-9
102	Effects of Systemically Administered Hydrocortisone on the Human Immunome	3-14-2016	Scientific Reports	https://doi.org/f8dmvw	https://greenelab.github.io/covid19-review/#ref-L6kwccjn			10.1038/srep23002
103	Soluble receptors for cytokines and growth factors: generation and biological function	6-1-1994	Biochemical Journal	https://doi.org/ggqmgd	https://greenelab.github.io/covid19-review/#ref-1EEloBjzn			10.1042/bj3000281
104	Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19	4-8-2020	New England Journal of Medicine	https://doi.org/ggrgz7	https://greenelab.github.io/covid19-review/#ref-8OnbWuhF			10.1056/nejmc2007575
105	Evidence of Airborne Transmission of the Severe Acute Respiratory Syndrome Virus	4-22-2004	New England Journal of Medicine	https://doi.org/bz7skr	https://greenelab.github.io/covid19-review/#ref-4GFhOcA1			10.1056/nejmoa032867
106	A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics	12-12-2019	New England Journal of Medicine	https://doi.org/ggqmx4	https://greenelab.github.io/covid19-review/#ref-gnfviuGp			10.1056/nejmoa1910993
107	First Case of 2019 Novel Coronavirus in the United States	1-31-2020	New England Journal of Medicine	https://doi.org/ggjvr6	https://greenelab.github.io/covid19-review/#ref-gleq16qf			10.1056/nejmoa2001191
108	Developing Covid-19 Vaccines at Pandemic Speed	3-30-2020	New England Journal of Medicine	https://doi.org/ggq8bc	https://greenelab.github.io/covid19-review/#ref-HyYY2agc			10.1056/nejmp2005630
109	Zinc activates NF-κB in HUT-78 cells	10-2001	Journal of Laboratory and Clinical Medicine	https://doi.org/cnc6fr	https://greenelab.github.io/covid19-review/#ref-1CEzU1G34			10.1067/mlc.2001.118108
110	Plasma proteome of severe acute respiratory syndrome analyzed by two-dimensional gel electrophoresis and mass spectrometry	11-30-2004	Proceedings of the National Academy of Sciences	https://doi.org/dtv8sx	https://greenelab.github.io/covid19-review/#ref-GpnngtWK			10.1073/pnas.0407992101
111	CD147 facilitates HIV-1 infection by interacting with virus-associated cyclophilin A	5-15-2001	Proceedings of the National Academy of Sciences	https://doi.org/cc4c7p	https://greenelab.github.io/covid19-review/#ref-yP8TXdq2			10.1073/pnas.111583198
112	Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution	4-28-2014	Proceedings of the National Academy of Sciences	https://doi.org/smr	https://greenelab.github.io/covid19-review/#ref-Ou3P9pGV			10.1073/pnas.1402074111
113	The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus	2-24-2020	Journal of Biological Chemistry	https://doi.org/ggqm6x	https://greenelab.github.io/covid19-review/#ref-YaxKcqq8			10.1074/jbc.ac120.013056
114	Vitamin C and the common cold	3-9-2007	British Journal of Nutrition	https://doi.org/fszhc6	https://greenelab.github.io/covid19-review/#ref-gZRPoTM9			10.1079/bjn19920004
115	Structural Design Principles for Delivery of Bioactive Components in Nutraceuticals and Functional Foods	6-16-2009	Critical Reviews in Food Science and Nutrition	https://doi.org/dt68m4	https://greenelab.github.io/covid19-review/#ref-xLPeszeO			10.1080/10408390902841529
116	The frontier between nutrition and pharma: The international regulatory framework of functional foods, food supplements and nutraceuticals	3-29-2019	Critical Reviews in Food Science and Nutrition	https://doi.org/ggqs3w	https://greenelab.github.io/covid19-review/#ref-lMhFSIiF			10.1080/10408398.2019.1592107
117	Product review on the monoclonal antibody palivizumab for prevention of respiratory syncytial virus infection	6-12-2017	Human Vaccines & Immunotherapeutics	https://doi.org/ggqbps	https://greenelab.github.io/covid19-review/#ref-cwbHiM1o			10.1080/21645515.2017.1337614
118	Neutralizing Antibodies in Patients with Severe Acute Respiratory Syndrome–Associated Coronavirus Infection	9-15-2004	The Journal of Infectious Diseases	https://doi.org/cgqj5b	https://greenelab.github.io/covid19-review/#ref-KULxo48U			10.1086/423286
119	Function of HAb18G/CD147 in Invasion of Host Cells by Severe Acute Respiratory Syndrome Coronavirus	3-2005	The Journal of Infectious Diseases	https://doi.org/cd8snd	https://greenelab.github.io/covid19-review/#ref-m9yLJ5Da			10.1086/427811
120	The Role of Zinc in Antiviral Immunity	7-2019	Advances in Nutrition	https://doi.org/ggqmgr	https://greenelab.github.io/covid19-review/#ref-IAOnO0Gj			10.1093/advances/nmz013
121	Zinc supplementation decreases incidence of infections in the elderly: effect of zinc on generation of cytokines and oxidative stress	3-2007	The American Journal of Clinical Nutrition	https://doi.org/ggqmgs	https://greenelab.github.io/covid19-review/#ref-kxuSwrCI			10.1093/ajcn/85.3.837
122	In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)	3-9-2020	Clinical Infectious Diseases	https://doi.org/ggpx7z	https://greenelab.github.io/covid19-review/#ref-1GBsnkeLK			10.1093/cid/ciaa237
123	Dysregulation of immune response in patients with COVID-19 in Wuhan, China	3-12-2020	Clinical Infectious Diseases	https://doi.org/ggpxcf	https://greenelab.github.io/covid19-review/#ref-6Y81C4P3			10.1093/cid/ciaa248
124	Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia	1-31-2020	Clinical Chemistry	https://doi.org/ggnbpp	https://greenelab.github.io/covid19-review/#ref-COEfjKo5			10.1093/clinchem/hvaa029
125	The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis	1-1-2015	Journal of Infectious Diseases	https://doi.org/f632n7	https://greenelab.github.io/covid19-review/#ref-RRx6YovP			10.1093/infdis/jiu396
126	The reproductive number of COVID-19 is higher compared to SARS coronavirus	2-13-2020	Journal of Travel Medicine	https://doi.org/ggnntv	https://greenelab.github.io/covid19-review/#ref-LHtuVmaq			10.1093/jtm/taaa021
127	CD147 (EMMPRIN/Basigin) in kidney diseases: from an inflammation and immune system viewpoint	7-2015	Nephrology Dialysis Transplantation	https://doi.org/ggq624	https://greenelab.github.io/covid19-review/#ref-BcOf65BE			10.1093/ndt/gfu302
128	Risk of infections in rheumatoid arthritis patients treated with tocilizumab	5-2012	Rheumatology	https://doi.org/d3b3rh	https://greenelab.github.io/covid19-review/#ref-TgV8gb30			10.1093/rheumatology/ker223
129	Vitamin C intake and susceptibility to pneumonia	9-1997	The Pediatric Infectious Disease Journal	https://doi.org/fkvs9d	https://greenelab.github.io/covid19-review/#ref-JARvpqRw			10.1097/00006454-199709000-00003
130	Novel coronavirus 2019-nCoV: early estimation of epidemiological parameters and epidemic predictions	1-28-2020	medRxiv	https://doi.org/dkzb	https://greenelab.github.io/covid19-review/#ref-ZzrrVDoE			10.1101/2020.01.23.20018549
131	Modelling the epidemic trend of the 2019 novel coronavirus outbreak in China	1-25-2020	bioRxiv	https://doi.org/ggqhzw	https://greenelab.github.io/covid19-review/#ref-Yj8Xh4Wz			10.1101/2020.01.23.916726
132	Time-varying transmission dynamics of Novel Coronavirus Pneumonia in China	2-13-2020	bioRxiv	https://doi.org/dkx9	https://greenelab.github.io/covid19-review/#ref-WLc2UMgQ			10.1101/2020.01.25.919787
133	Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody	1-28-2020	bioRxiv	https://doi.org/ggjqfd	https://greenelab.github.io/covid19-review/#ref-1HLSeqnY8			10.1101/2020.01.28.923011
134	Integrative Bioinformatics Analysis Provides Insight into the Molecular Mechanisms of 2019-nCoV	2-5-2020	medRxiv	https://doi.org/ggrbd8	https://greenelab.github.io/covid19-review/#ref-lOQPScZt			10.1101/2020.02.03.20020206
135	Diarrhea may be underestimated: a missing link in 2019 novel coronavirus	2-17-2020	medRxiv	https://doi.org/ggrbdw	https://greenelab.github.io/covid19-review/#ref-rL9IRhVy			10.1101/2020.02.03.20020289
136	Specific ACE2 Expression in Cholangiocytes May Cause Liver Damage After 2019-nCoV Infection	2-4-2020	bioRxiv	https://doi.org/ggq626	https://greenelab.github.io/covid19-review/#ref-BHQvMYPG			10.1101/2020.02.03.931766
137	ACE2 expression by colonic epithelial cells is associated with viral infection, immunity and energy metabolism	2-7-2020	medRxiv	https://doi.org/ggrfbx	https://greenelab.github.io/covid19-review/#ref-ViWCb8MJ			10.1101/2020.02.05.20020545
138	Potentially highly potent drugs for 2019-nCoV	2-13-2020	bioRxiv	https://doi.org/ggrbj5	https://greenelab.github.io/covid19-review/#ref-7zBwK1wn			10.1101/2020.02.05.936013
139	Clinical characteristics of 2019 novel coronavirus infection in China	2-9-2020	medRxiv	https://doi.org/ggkj9s	https://greenelab.github.io/covid19-review/#ref-bgrzawWp			10.1101/2020.02.06.20020974
140	The Pathogenicity of SARS-CoV-2 in hACE2 Transgenic Mice	2-28-2020	bioRxiv	https://doi.org/dph2	https://greenelab.github.io/covid19-review/#ref-MgLBA5m			10.1101/2020.02.07.939389
141	Caution on Kidney Dysfunctions of COVID-19 Patients	3-27-2020	medRxiv	https://doi.org/ggq627	https://greenelab.github.io/covid19-review/#ref-1Acv5UMSt			10.1101/2020.02.08.20021212
142	The immune vulnerability landscape of the 2019 Novel Coronavirus, SARS-CoV-2	3-23-2020	bioRxiv	https://doi.org/ggq628	https://greenelab.github.io/covid19-review/#ref-QhE5mVCc			10.1101/2020.02.08.939553
143	Single-cell Analysis of ACE2 Expression in Human Kidneys and Bladders Reveals a Potential Route of 2019-nCoV Infection	2-18-2020	bioRxiv	https://doi.org/ggq629	https://greenelab.github.io/covid19-review/#ref-16Xj27QYj			10.1101/2020.02.08.939892
144	Neutrophil-to-Lymphocyte Ratio Predicts Severe Illness Patients with 2019 Novel Coronavirus in the Early Stage	2-12-2020	medRxiv	https://doi.org/ggrbdx	https://greenelab.github.io/covid19-review/#ref-gK5e7Yhl			10.1101/2020.02.10.20021584
145	Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP)	2-12-2020	medRxiv	https://doi.org/ggq63b	https://greenelab.github.io/covid19-review/#ref-P4assQHj			10.1101/2020.02.10.20021832
146	Epidemiological and Clinical Characteristics of 17 Hospitalized Patients with 2019 Novel Coronavirus Infections Outside Wuhan, China	2-12-2020	medRxiv	https://doi.org/ggq63c	https://greenelab.github.io/covid19-review/#ref-TXlNzmXd			10.1101/2020.02.11.20022053
147	ACE2 Expression in Kidney and Testis May Cause Kidney and Testis Damage After 2019-nCoV Infection	2-13-2020	medRxiv	https://doi.org/ggq63d	https://greenelab.github.io/covid19-review/#ref-15K5Ovntj			10.1101/2020.02.12.20022418
148	Aberrant pathogenic GM-CSF <sup>+</sup> T cells and inflammatory CD14 <sup>+</sup> CD16 <sup>+</sup> monocytes in severe pulmonary syndrome patients of a new coronavirus	2-20-2020	bioRxiv	https://doi.org/ggq63f	https://greenelab.github.io/covid19-review/#ref-Bgo7Cmj3			10.1101/2020.02.12.945576
149	Clinical Characteristics of 2019 Novel Infected Coronavirus Pneumonia：A Systemic Review and Meta-analysis	2-17-2020	medRxiv	https://doi.org/ggrgbq	https://greenelab.github.io/covid19-review/#ref-4Z1pEioX			10.1101/2020.02.14.20021535
150	Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients	2-22-2020	medRxiv	https://doi.org/ggq63g	https://greenelab.github.io/covid19-review/#ref-zTGzuiTI			10.1101/2020.02.16.20023671
151	Clinical and immunologic features in severe and moderate forms of Coronavirus Disease 2019	2-19-2020	medRxiv	https://doi.org/ggq63h	https://greenelab.github.io/covid19-review/#ref-1EIEx8Qe4			10.1101/2020.02.16.20023903
152	SARS-CoV-2 and SARS-CoV Spike-RBD Structure and Receptor Binding Comparison and Potential Implications on Neutralizing Antibody and Vaccine Development	2-20-2020	bioRxiv	https://doi.org/ggq63j	https://greenelab.github.io/covid19-review/#ref-41WAtZmB			10.1101/2020.02.16.951723
153	Protection of Rhesus Macaque from SARS-Coronavirus challenge by recombinant adenovirus vaccine	2-21-2020	bioRxiv	https://doi.org/ggq63k	https://greenelab.github.io/covid19-review/#ref-NPxs7bbq			10.1101/2020.02.17.951939
154	Reduction and Functional Exhaustion of T Cells in Patients with Coronavirus Disease 2019 (COVID-19)	2-20-2020	medRxiv	https://doi.org/ggq63m	https://greenelab.github.io/covid19-review/#ref-f50ahNxF			10.1101/2020.02.18.20024364
155	Clinical characteristics of 25 death cases infected with COVID-19 pneumonia: a retrospective review of medical records in a single medical center, Wuhan, China	2-25-2020	medRxiv	https://doi.org/ggq63n	https://greenelab.github.io/covid19-review/#ref-EwNi3WJq			10.1101/2020.02.19.20025239
156	SARS-CoV-2 infection does not significantly cause acute renal injury: an analysis of 116 hospitalized patients with COVID-19 in a single hospital, Wuhan, China	2-23-2020	medRxiv	https://doi.org/ggq63p	https://greenelab.github.io/covid19-review/#ref-KG5Lg65z			10.1101/2020.02.19.20025288
157	Pangolin homology associated with 2019-nCoV	2-20-2020	bioRxiv	https://doi.org/ggpvpt	https://greenelab.github.io/covid19-review/#ref-eQIU1Nbs			10.1101/2020.02.19.950253
158	Potential T-cell and B-cell Epitopes of 2019-nCoV	3-18-2020	bioRxiv	https://doi.org/ggq63q	https://greenelab.github.io/covid19-review/#ref-hdSafq1o			10.1101/2020.02.19.955484
159	Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein	2-20-2020	bioRxiv	https://doi.org/ggrgbr	https://greenelab.github.io/covid19-review/#ref-8xnxgpag			10.1101/2020.02.19.956581
160	Breadth of concomitant immune responses underpinning viral clearance and patient recovery in a non-severe case of COVID-19	2-23-2020	medRxiv	https://doi.org/ggq63r	https://greenelab.github.io/covid19-review/#ref-QdimT8mN			10.1101/2020.02.20.20025841
161	The landscape of lung bronchoalveolar immune cells in COVID-19 revealed by single-cell RNA sequencing	2-26-2020	medRxiv	https://doi.org/ggq63s	https://greenelab.github.io/covid19-review/#ref-tVkKuIJt			10.1101/2020.02.23.20026690
162	Can routine laboratory tests discriminate 2019 novel coronavirus infected pneumonia from other community-acquired pneumonia?	2-25-2020	medRxiv	https://doi.org/ggq63t	https://greenelab.github.io/covid19-review/#ref-FOVDaThy			10.1101/2020.02.25.20024711
163	Correlation Analysis Between Disease Severity and Inflammation-related Parameters in Patients with COVID-19 Pneumonia	2-26-2020	medRxiv	https://doi.org/ggq63v	https://greenelab.github.io/covid19-review/#ref-1Du40IOOH			10.1101/2020.02.25.20025643
164	An Effective CTL Peptide Vaccine for Ebola Zaire Based on Survivors’ CD8+ Targeting of a Particular Nucleocapsid Protein Epitope with Potential Implications for COVID-19 Vaccine Design	4-6-2020	bioRxiv	https://doi.org/ggq63x	https://greenelab.github.io/covid19-review/#ref-1DTLMIDoM			10.1101/2020.02.25.963546
165	Epitope-based peptide vaccine design and target site characterization against novel coronavirus disease caused by SARS-CoV-2	2-27-2020	bioRxiv	https://doi.org/ggnqwt	https://greenelab.github.io/covid19-review/#ref-9spK49tt			10.1101/2020.02.25.965434
166	The definition and risks of Cytokine Release Syndrome-Like in 11 COVID-19-Infected Pneumonia critically ill patients: Disease Characteristics and Retrospective Analysis	2-27-2020	medRxiv	https://doi.org/ggrgbs	https://greenelab.github.io/covid19-review/#ref-qg1bmQng			10.1101/2020.02.26.20026989
167	Clinical characteristics of 36 non-survivors with COVID-19 in Wuhan, China	3-5-2020	medRxiv	https://doi.org/ggq63z	https://greenelab.github.io/covid19-review/#ref-YODgfrtM			10.1101/2020.02.27.20029009
168	The level of plasma C-reactive protein is closely related to the liver injury in patients with COVID-19	3-3-2020	medRxiv	https://doi.org/ggq632	https://greenelab.github.io/covid19-review/#ref-5CGbn9Jj			10.1101/2020.02.28.20028514
169	Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely associated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients	3-3-2020	medRxiv	https://doi.org/ggq633	https://greenelab.github.io/covid19-review/#ref-T0BDaXkw			10.1101/2020.02.29.20029520
170	Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study	3-3-2020	medRxiv	https://doi.org/ggq634	https://greenelab.github.io/covid19-review/#ref-uIwTzZkJ			10.1101/2020.03.01.20029074
171	The potential role of IL-6 in monitoring severe case of coronavirus disease 2019	3-10-2020	medRxiv	https://doi.org/ggq635	https://greenelab.github.io/covid19-review/#ref-1GMxHWnxN			10.1101/2020.03.01.20029769
172	Clinical and Laboratory Profiles of 75 Hospitalized Patients with Novel Coronavirus Disease 2019 in Hefei, China	3-6-2020	medRxiv	https://doi.org/ggq636	https://greenelab.github.io/covid19-review/#ref-1B0vBwv1q			10.1101/2020.03.01.20029785
173	Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome	3-6-2020	medRxiv	https://doi.org/ggq637	https://greenelab.github.io/covid19-review/#ref-RyXNw87v			10.1101/2020.03.02.20029975
174	Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019	3-2-2020	medRxiv	https://doi.org/ggrbj6	https://greenelab.github.io/covid19-review/#ref-5HXuCa5t			10.1101/2020.03.02.20030189
175	Restoration of leukomonocyte counts is associated with viral clearance in COVID-19 hospitalized patients	3-6-2020	medRxiv	https://doi.org/ggq639	https://greenelab.github.io/covid19-review/#ref-uCyoHtV3			10.1101/2020.03.03.20030437
176	Clinical findings in critical ill patients infected with SARS-Cov-2 in Guangdong Province, China: a multi-center, retrospective, observational study	3-6-2020	medRxiv	https://doi.org/ggq64b	https://greenelab.github.io/covid19-review/#ref-USOnp7c0			10.1101/2020.03.03.20030668
177	Multi-epitope vaccine design using an immunoinformatics approach for 2019 novel coronavirus in China (SARS-CoV-2)	3-3-2020	bioRxiv	https://doi.org/ggq64c	https://greenelab.github.io/covid19-review/#ref-14OLQIYK0			10.1101/2020.03.03.962332
178	Clinical Features of Patients Infected with the 2019 Novel Coronavirus (COVID-19) in Shanghai, China	3-6-2020	medRxiv	https://doi.org/ggq64d	https://greenelab.github.io/covid19-review/#ref-12ilBRq6I			10.1101/2020.03.04.20030395
179	Serological detection of 2019-nCoV respond to the epidemic: A useful complement to nucleic acid testing	3-10-2020	medRxiv	https://doi.org/ggq64f	https://greenelab.github.io/covid19-review/#ref-IPJURDxi			10.1101/2020.03.04.20030916
180	Human Kidney is a Target for Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection	4-10-2020	medRxiv	https://doi.org/ggq64g	https://greenelab.github.io/covid19-review/#ref-H0nvocJz			10.1101/2020.03.04.20031120
181	COVID-19 early warning score: a multi-parameter screening tool to identify highly suspected patients	3-8-2020	medRxiv	https://doi.org/ggq64h	https://greenelab.github.io/covid19-review/#ref-KHNnjP7M			10.1101/2020.03.05.20031906
182	LY6E impairs coronavirus fusion and confers immune control of viral disease	3-7-2020	bioRxiv	https://doi.org/dpvn	https://greenelab.github.io/covid19-review/#ref-19xwRoatu			10.1101/2020.03.05.979260
183	A preliminary study on serological assay for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 238 admitted hospital patients	3-8-2020	medRxiv	https://doi.org/ggq64j	https://greenelab.github.io/covid19-review/#ref-574aSa8C			10.1101/2020.03.06.20031856
184	Rapid Detection of 2019 Novel Coronavirus SARS-CoV-2 Using a CRISPR-based DETECTR Lateral Flow Assay	3-27-2020	medRxiv	https://doi.org/ggrmwt	https://greenelab.github.io/covid19-review/#ref-1dxrDub1			10.1101/2020.03.06.20032334
185	Monoclonal antibodies for the S2 subunit of spike of SARS-CoV cross-react with the newly-emerged SARS-CoV-2	3-7-2020	bioRxiv	https://doi.org/ggrbj7	https://greenelab.github.io/covid19-review/#ref-NT3T9a8H			10.1101/2020.03.06.980037
186	Mortality of COVID-19 is Associated with Cellular Immune Function Compared to Immune Function in Chinese Han Population	3-13-2020	medRxiv	https://doi.org/ggq64k	https://greenelab.github.io/covid19-review/#ref-1GEbBtBgh			10.1101/2020.03.08.20031229
187	First 12 patients with coronavirus disease 2019 (COVID-19) in the United States	3-12-2020	medRxiv	https://doi.org/ggqm6z	https://greenelab.github.io/covid19-review/#ref-zoLViMNg			10.1101/2020.03.09.20032896
188	Retrospective Analysis of Clinical Features in 101 Death Cases with COVID-19	3-17-2020	medRxiv	https://doi.org/ggq64n	https://greenelab.github.io/covid19-review/#ref-WuHcOc9T			10.1101/2020.03.09.20033068
189	Relationship between the ABO Blood Group and the COVID-19 Susceptibility	3-27-2020	medRxiv	https://doi.org/ggpn3d	https://greenelab.github.io/covid19-review/#ref-1DbV444Pj			10.1101/2020.03.11.20031096
190	The inhaled corticosteroid ciclesonide blocks coronavirus RNA replication by targeting viral NSP15	3-12-2020	bioRxiv	https://doi.org/ggq64p	https://greenelab.github.io/covid19-review/#ref-JwL9G6bd			10.1101/2020.03.11.987016
191	A human monoclonal antibody blocking SARS-CoV-2 infection	3-12-2020	bioRxiv	https://doi.org/ggnw4t	https://greenelab.github.io/covid19-review/#ref-XcuzhxrJ			10.1101/2020.03.11.987958
192	Heat inactivation of serum interferes with the immunoanalysis of antibodies to SARS-CoV-2	3-16-2020	medRxiv	https://doi.org/ggq646	https://greenelab.github.io/covid19-review/#ref-p1c9Nilh			10.1101/2020.03.12.20034231
193	Immune phenotyping based on neutrophil-to-lymphocyte ratio and IgG predicts disease severity and outcome for patients with COVID-19	3-16-2020	medRxiv	https://doi.org/ggq64q	https://greenelab.github.io/covid19-review/#ref-1CwCTXPqj			10.1101/2020.03.12.20035048
194	The architecture of SARS-CoV-2 transcriptome	3-14-2020	bioRxiv	https://doi.org/ggpx9q	https://greenelab.github.io/covid19-review/#ref-hRVfFbS			10.1101/2020.03.12.988865
195	Ocular conjunctival inoculation of SARS-CoV-2 can cause mild COVID-19 in Rhesus macaques	3-30-2020	bioRxiv	https://doi.org/ggq64r	https://greenelab.github.io/covid19-review/#ref-unVgVIfU			10.1101/2020.03.13.990036
196	Reinfection could not occur in SARS-CoV-2 infected rhesus macaques	3-14-2020	bioRxiv	https://doi.org/ggn8r8	https://greenelab.github.io/covid19-review/#ref-3XqFhi8l			10.1101/2020.03.13.990226
197	A highly conserved cryptic epitope in the receptor-binding domains of SARS-CoV-2 and SARS-CoV	3-14-2020	bioRxiv	https://doi.org/ggq64s	https://greenelab.github.io/covid19-review/#ref-6gQxRkWM			10.1101/2020.03.13.991570
198	Highly accurate and sensitive diagnostic detection of SARS-CoV-2 by digital PCR	3-30-2020	medRxiv	https://doi.org/ggqnqh	https://greenelab.github.io/covid19-review/#ref-UYD5T2mp			10.1101/2020.03.14.20036129
199	SARS-CoV-2 invades host cells via a novel route: CD147-spike protein	3-14-2020	bioRxiv	https://doi.org/ggq64t	https://greenelab.github.io/covid19-review/#ref-14y8UvAbH			10.1101/2020.03.14.988345
200	Blood single cell immune profiling reveals the interferon-MAPK pathway mediated adaptive immune response for COVID-19	3-17-2020	medRxiv	https://doi.org/ggq64v	https://greenelab.github.io/covid19-review/#ref-18l4l0nLX			10.1101/2020.03.15.20033472
201	Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections	3-17-2020	bioRxiv	https://doi.org/ggq64w	https://greenelab.github.io/covid19-review/#ref-dM1rOHmH			10.1101/2020.03.15.993097
202	The feasibility of convalescent plasma therapy in severe COVID-19 patients: a pilot study	3-23-2020	medRxiv	https://doi.org/dqrs	https://greenelab.github.io/covid19-review/#ref-UENoLkhz			10.1101/2020.03.16.20036145
203	Hydroxychloroquine and Azithromycin as a treatment of COVID-19: preliminary results of an open-label non-randomized clinical trial	3-20-2020	medRxiv	https://doi.org/dqbv	https://greenelab.github.io/covid19-review/#ref-Xbkby2Jr			10.1101/2020.03.16.20037135
204	Recapitulation of SARS-CoV-2 Infection and Cholangiocyte Damage with Human Liver Organoids	3-17-2020	bioRxiv	https://doi.org/ggq648	https://greenelab.github.io/covid19-review/#ref-OuDMtCRl			10.1101/2020.03.16.990317
205	The sequence of human ACE2 is suboptimal for binding the S spike protein of SARS coronavirus 2	4-6-2020	bioRxiv	https://doi.org/ggrbj8	https://greenelab.github.io/covid19-review/#ref-3VPi509z			10.1101/2020.03.16.994236
206	A serological assay to detect SARS-CoV-2 seroconversion in humans	3-18-2020	medRxiv	https://doi.org/ggpn83	https://greenelab.github.io/covid19-review/#ref-yJW1RVQb	https://github.com/greenelab/covid19-review/issues/84	New Paper, Review Needed, diagnostic, immunology, virology	10.1101/2020.03.17.20037713
207	Comparative Pathogenesis Of COVID-19, MERS And SARS In A Non-Human Primate Model	3-17-2020	bioRxiv	https://doi.org/ggq649	https://greenelab.github.io/covid19-review/#ref-1EcOLnVXk			10.1101/2020.03.17.995639
208	Investigating the Impact of Asymptomatic Carriers on COVID-19 Transmission	3-31-2020	medRxiv	https://doi.org/ggqnvp	https://greenelab.github.io/covid19-review/#ref-OvFueDLZ			10.1101/2020.03.18.20037994
209	Antibody responses to SARS-CoV-2 in COVID-19 patients: the perspective application of serological tests in clinical practice	3-20-2020	medRxiv	https://doi.org/ggpvz3	https://greenelab.github.io/covid19-review/#ref-Y9g1sQ1Y			10.1101/2020.03.18.20038018
210	SARS-CoV-2 specific antibody responses in COVID-19 patients	3-20-2020	medRxiv	https://doi.org/ggpvz2	https://greenelab.github.io/covid19-review/#ref-1BLNvgEao			10.1101/2020.03.18.20038059
211	A brief review of antiviral drugs evaluated in registered clinical trials for COVID-19	3-27-2020	medRxiv	https://doi.org/ggq65b	https://greenelab.github.io/covid19-review/#ref-K41YFM2N			10.1101/2020.03.18.20038190
212	ACE-2 Expression in the Small Airway Epithelia of Smokers and COPD Patients: Implications for COVID-19	3-23-2020	medRxiv	https://doi.org/dqx2	https://greenelab.github.io/covid19-review/#ref-eTsOvBVf			10.1101/2020.03.18.20038455
213	Dynamic profile of severe or critical COVID-19 cases	3-20-2020	medRxiv	https://doi.org/ggrbj9	https://greenelab.github.io/covid19-review/#ref-18KZGwJ0J			10.1101/2020.03.18.20038513
214	Association between Clinical, Laboratory and CT Characteristics and RT-PCR Results in the Follow-up of COVID-19 patients	3-23-2020	medRxiv	https://doi.org/ggq65c	https://greenelab.github.io/covid19-review/#ref-1BJXDZ04c			10.1101/2020.03.19.20038315
215	An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 and multiple endemic, epidemic and bat coronavirus	3-20-2020	bioRxiv	https://doi.org/ggrbkb	https://greenelab.github.io/covid19-review/#ref-iMCz5Twj			10.1101/2020.03.19.997890
216	Estimating the reproduction number of COVID-19 in Iran using epidemic modeling	3-29-2020	medRxiv	https://doi.org/ggqhzx	https://greenelab.github.io/covid19-review/#ref-TH4ymqvJ			10.1101/2020.03.20.20038422
217	Global profiling of SARS-CoV-2 specific IgG/ IgM responses of convalescents using a proteome microarray	3-27-2020	medRxiv	https://doi.org/ggq65g	https://greenelab.github.io/covid19-review/#ref-LIf5SSUs			10.1101/2020.03.20.20039495
218	Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs	3-28-2020	bioRxiv	https://doi.org/ggq65h	https://greenelab.github.io/covid19-review/#ref-ZDP9vSpg			10.1101/2020.03.20.999730
219	Respiratory disease and virus shedding in rhesus macaques inoculated with SARS-CoV-2	3-21-2020	bioRxiv	https://doi.org/ggq65j	https://greenelab.github.io/covid19-review/#ref-LYFzvlzE			10.1101/2020.03.21.001628
220	ACE2 Expression is Increased in the Lungs of Patients with Comorbidities Associated with Severe COVID-19	3-27-2020	medRxiv	https://doi.org/ggq65k	https://greenelab.github.io/covid19-review/#ref-wjtVy2v0			10.1101/2020.03.21.20040261
221	Epidemiological parameters of coronavirus disease 2019: a pooled analysis of publicly reported individual data of 1155 cases from seven countries	3-24-2020	medRxiv	https://doi.org/ggqhzz	https://greenelab.github.io/covid19-review/#ref-vITui6ac			10.1101/2020.03.21.20040329
222	Meplazumab treats COVID-19 pneumonia: an open-labelled, concurrent controlled add-on clinical trial	3-24-2020	medRxiv	https://doi.org/ggq65m	https://greenelab.github.io/covid19-review/#ref-DFhY5nfb	https://github.com/greenelab/covid19-review/issues/169	New Paper, Review Needed, therapeutic	10.1101/2020.03.21.20040691
223	Potent human neutralizing antibodies elicited by SARS-CoV-2 infection	3-26-2020	bioRxiv	https://doi.org/ggp7t4	https://greenelab.github.io/covid19-review/#ref-GhJYjnft			10.1101/2020.03.21.990770
224	Characterisation of the transcriptome and proteome of SARS-CoV-2 using direct RNA sequencing and tandem mass spectrometry reveals evidence for a cell passage induced in-frame deletion in the spike glycoprotein that removes the furin-like cleavage site	3-24-2020	bioRxiv	https://doi.org/ggq65n	https://greenelab.github.io/covid19-review/#ref-bCYYaFKM			10.1101/2020.03.22.002204
225	A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing	3-22-2020	bioRxiv	https://doi.org/ggpptg	https://greenelab.github.io/covid19-review/#ref-phJM8g2Y	https://github.com/greenelab/covid19-review/issues/60	Additional Reviews Welcome, New Paper, pharmacology, virology	10.1101/2020.03.22.002386
226	First Clinical Study Using HCV Protease Inhibitor Danoprevir to Treat Naive and Experienced COVID-19 Patients	3-24-2020	medRxiv	https://doi.org/ggrgbt	https://greenelab.github.io/covid19-review/#ref-RTIk8DTo	https://github.com/greenelab/covid19-review/issues/130	New Paper, Review Needed, therapeutic	10.1101/2020.03.22.20034041
227	Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial	3-31-2020	medRxiv	https://doi.org/ggqm4v	https://greenelab.github.io/covid19-review/#ref-wzHb7Mj5	https://github.com/greenelab/covid19-review/issues/123	Additional Reviews Welcome, New Paper, therapeutic, virology	10.1101/2020.03.22.20040758
228	Using early data to estimate the actual infection fatality ratio from COVID-19 in France	4-7-2020	medRxiv	https://doi.org/ggqhz2	https://greenelab.github.io/covid19-review/#ref-itj26agd			10.1101/2020.03.22.20040915
229	Serology characteristics of SARS-CoV-2 infection since the exposure and post symptoms onset	3-27-2020	medRxiv	https://doi.org/ggrbkc	https://greenelab.github.io/covid19-review/#ref-lnuNSHEW			10.1101/2020.03.23.20041707
230	SARS-CoV-2 launches a unique transcriptional signature from in vitro, ex vivo, and in vivo systems	3-24-2020	bioRxiv	https://doi.org/ggq65q	https://greenelab.github.io/covid19-review/#ref-aNSdARwe			10.1101/2020.03.24.004655
231	A New Predictor of Disease Severity in Patients with COVID-19 in Wuhan, China	3-27-2020	medRxiv	https://doi.org/ggq65r	https://greenelab.github.io/covid19-review/#ref-EWZmuLvu			10.1101/2020.03.24.20042119
232	Metabolic disturbances and inflammatory dysfunction predict severity of coronavirus disease 2019 (COVID-19): a retrospective study	3-26-2020	medRxiv	https://doi.org/ggq65s	https://greenelab.github.io/covid19-review/#ref-95sQSGzx			10.1101/2020.03.24.20042283
233	Viral Kinetics and Antibody Responses in Patients with COVID-19	3-26-2020	medRxiv	https://doi.org/ggq65t	https://greenelab.github.io/covid19-review/#ref-btVuoX6V			10.1101/2020.03.24.20042382
234	COVID-19 infection induces readily detectable morphological and inflammation-related phenotypic changes in peripheral blood monocytes, the severity of which correlate with patient outcome	3-26-2020	medRxiv	https://doi.org/ggq65v	https://greenelab.github.io/covid19-review/#ref-1FZgghazg			10.1101/2020.03.24.20042655
235	Correlation between universal BCG vaccination policy and reduced morbidity and mortality for COVID-19: an epidemiological study	3-28-2020	medRxiv	https://doi.org/ggq65w	https://greenelab.github.io/covid19-review/#ref-15gdkEnfn			10.1101/2020.03.24.20042937
236	Non-neural expression of SARS-CoV-2 entry genes in the olfactory epithelium suggests mechanisms underlying anosmia in COVID-19 patients	3-28-2020	bioRxiv	https://doi.org/ggqr4m	https://greenelab.github.io/covid19-review/#ref-12oDb7aki	https://github.com/greenelab/covid19-review/issues/135	New Paper, Review Needed, biostatistics, diagnostic, virology	10.1101/2020.03.25.009084
237	Cigarette smoke triggers the expansion of a subpopulation of respiratory epithelial cells that express the SARS-CoV-2 receptor ACE2	3-31-2020	bioRxiv	https://doi.org/ggq65x	https://greenelab.github.io/covid19-review/#ref-t4vofknR			10.1101/2020.03.28.013672
238	The comparative superiority of IgM-IgG antibody test to real-time reverse transcriptase PCR detection for SARS-CoV-2 infection diagnosis	3-30-2020	medRxiv	https://doi.org/ggqtp5	https://greenelab.github.io/covid19-review/#ref-k1E3DuFN			10.1101/2020.03.28.20045765
239	Virus-host interactome and proteomic survey of PMBCs from COVID-19 patients reveal potential virulence factors influencing SARS-CoV-2 pathogenesis	4-2-2020	bioRxiv	https://doi.org/ggrgbv	https://greenelab.github.io/covid19-review/#ref-NLoN4aYj			10.1101/2020.03.31.019216
240	Short-course tocilizumab increases risk of hepatitis B virus reactivation in patients with rheumatoid arthritis: a prospective clinical observation	7-2017	International Journal of Rheumatic Diseases	https://doi.org/f9pbc5	https://greenelab.github.io/covid19-review/#ref-IJzmtJOr			10.1111/1756-185x.13010
241	Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology?	3-2013	British Journal of Clinical Pharmacology	https://doi.org/ggqmgg	https://greenelab.github.io/covid19-review/#ref-JNyhLAfe			10.1111/j.1365-2125.2012.04374.x
242	The concept of R <sub>o</sub> in epidemic theory	3-1996	Statistica Neerlandica	https://doi.org/d29ch4	https://greenelab.github.io/covid19-review/#ref-16CD4voW1			10.1111/j.1467-9574.1996.tb01482.x
243	Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS-associated coronavirus	12-2004	Clinical Microbiology and Infection	https://doi.org/cwwg87	https://greenelab.github.io/covid19-review/#ref-3gp7t98X			10.1111/j.1469-0691.2004.01009.x
244	Acute renal impairment in coronavirus-associated severe acute respiratory syndrome	2-2005	Kidney International	https://doi.org/b7tgtx	https://greenelab.github.io/covid19-review/#ref-DMaiZBE1			10.1111/j.1523-1755.2005.67130.x
245	ASCORBIC ACID FUNCTION AND METABOLISM DURING COLDS	9-1975	Annals of the New York Academy of Sciences	https://doi.org/bjfdtb	https://greenelab.github.io/covid19-review/#ref-10nBT1HbX			10.1111/j.1749-6632.1975.tb29312.x
246	Innate or Adaptive Immunity? The Example of Natural Killer Cells	1-6-2011	Science	https://doi.org/ckzg9g	https://greenelab.github.io/covid19-review/#ref-7ElRN12v			10.1126/science.1198687
247	A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield	10-13-2011	Science	https://doi.org/bzqv8c	https://greenelab.github.io/covid19-review/#ref-14motyCOm			10.1126/science.1213256
248	Population Dynamics of Immune Responses to Persistent Viruses	4-5-1996	Science	https://doi.org/fqgprd	https://greenelab.github.io/covid19-review/#ref-lwH4gcts			10.1126/science.272.5258.74
249	Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy	7-23-2015	Science	https://doi.org/f7kc8d	https://greenelab.github.io/covid19-review/#ref-Q9tXjG1R			10.1126/science.aaa1663
250	Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation	2-19-2020	Science	https://doi.org/ggmtk2	https://greenelab.github.io/covid19-review/#ref-CqQVkaqj			10.1126/science.abb2507
251	Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2)	3-16-2020	Science	https://doi.org/ggn6c2	https://greenelab.github.io/covid19-review/#ref-mHYmt0mv			10.1126/science.abb3221
252	Did an experimental drug help a U.S. coronavirus patient?	3-13-2020	Science	https://doi.org/ggqm62	https://greenelab.github.io/covid19-review/#ref-D4HwvRMd			10.1126/science.abb7243
253	The standard coronavirus test, if available, works well—but can new diagnostics help in this pandemic?	3-22-2020	Science	https://doi.org/ggq9wm	https://greenelab.github.io/covid19-review/#ref-NT5mrVGY			10.1126/science.abb8400
254	Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses	6-28-2017	Science Translational Medicine	https://doi.org/gc3grb	https://greenelab.github.io/covid19-review/#ref-1H0NPTMw9			10.1126/scitranslmed.aal3653
255	Preclinical Characteristics of the Hepatitis C Virus NS3/4A Protease Inhibitor ITMN-191 (R7227)	9-29-2008	Antimicrobial Agents and Chemotherapy	https://doi.org/btpg52	https://greenelab.github.io/covid19-review/#ref-YoCPtq6P			10.1128/aac.00699-08
256	Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell Culture	8-2014	Antimicrobial Agents and Chemotherapy	https://doi.org/f59p8v	https://greenelab.github.io/covid19-review/#ref-2AASZDqa			10.1128/aac.03011-14
257	PPAR-γ in Macrophages Limits Pulmonary Inflammation and Promotes Host Recovery following Respiratory Viral Infection	4-17-2019	Journal of Virology	https://doi.org/ggq652	https://greenelab.github.io/covid19-review/#ref-WBN5f37b			10.1128/jvi.00030-19
258	Modifications to the Hemagglutinin Cleavage Site Control the Virulence of a Neurotropic H1N1 Influenza Virus	6-16-2010	Journal of Virology	https://doi.org/drs2zt	https://greenelab.github.io/covid19-review/#ref-16tHVjVzu			10.1128/jvi.00797-10
259	<i>In Vitro</i> Neutralization Is Not Predictive of Prophylactic Efficacy of Broadly Neutralizing Monoclonal Antibodies CR6261 and CR9114 against Lethal H2 Influenza Virus Challenge in Mice	12-15-2017	Journal of Virology	https://doi.org/ggqbpt	https://greenelab.github.io/covid19-review/#ref-O1whWg6Q			10.1128/jvi.01603-17
260	Importance of Neutralizing Monoclonal Antibodies Targeting Multiple Antigenic Sites on the Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein To Avoid Neutralization Escape	4-27-2018	Journal of Virology	https://doi.org/ggqbpv	https://greenelab.github.io/covid19-review/#ref-hvjXMm9H			10.1128/jvi.02002-17
261	Lethal Infection of K18-hACE2 Mice Infected with Severe Acute Respiratory Syndrome Coronavirus	11-1-2006	Journal of Virology	https://doi.org/b2dr3s	https://greenelab.github.io/covid19-review/#ref-NzFgXYvQ			10.1128/jvi.02012-06
262	CD147/EMMPRIN Acts as a Functional Entry Receptor for Measles Virus on Epithelial Cells	5-1-2010	Journal of Virology	https://doi.org/dpcsqg	https://greenelab.github.io/covid19-review/#ref-X8l1n4zY			10.1128/jvi.02168-09
263	Prior Infection and Passive Transfer of Neutralizing Antibody Prevent Replication of Severe Acute Respiratory Syndrome Coronavirus in the Respiratory Tract of Mice	4-1-2004	Journal of Virology	https://doi.org/b8wr7c	https://greenelab.github.io/covid19-review/#ref-rXzkS3gA			10.1128/jvi.78.7.3572-3577.2004
264	Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease	3-6-2018	mBio	https://doi.org/gc45v6	https://greenelab.github.io/covid19-review/#ref-lIko9Imd			10.1128/mbio.00221-18
265	Into the Eye of the Cytokine Storm	3-5-2012	Microbiology and Molecular Biology Reviews	https://doi.org/f4n9h2	https://greenelab.github.io/covid19-review/#ref-bZMKqj6e			10.1128/mmbr.05015-11
266	Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review	1-2010	Annals of the Rheumatic Diseases	https://doi.org/dfrv2q	https://greenelab.github.io/covid19-review/#ref-IeML5mBm			10.1136/ard.2008.101766
267	Broadly Neutralizing Antiviral Antibodies	3-21-2013	Annual Review of Immunology	https://doi.org/gf25g8	https://greenelab.github.io/covid19-review/#ref-yumBaJ6U			10.1146/annurev-immunol-032712-095916
268	Vitamin C Mitigates Oxidative Stress and Tumor Necrosis Factor-Alpha in Severe Community-Acquired Pneumonia and LPS-Induced Macrophages	2014	Mediators of Inflammation	https://doi.org/f6nb5f	https://greenelab.github.io/covid19-review/#ref-9czQt5cR			10.1155/2014/426740
269	Life Threatening Severe QTc Prolongation in Patient with Systemic Lupus Erythematosus due to Hydroxychloroquine	2016	Case Reports in Cardiology	https://doi.org/ggqzrc	https://greenelab.github.io/covid19-review/#ref-dY9kXLAS			10.1155/2016/4626279
270	The Biology and Medical Implications of Interleukin-6	4-3-2014	Cancer Immunology Research	https://doi.org/f56dzb	https://greenelab.github.io/covid19-review/#ref-eW4MC6Do			10.1158/2326-6066.cir-14-0022
271	Cytokine Balance in the Lungs of Patients with Acute Respiratory Distress Syndrome	11-15-2001	American Journal of Respiratory and Critical Care Medicine	https://doi.org/ggqfq7	https://greenelab.github.io/covid19-review/#ref-f61jsRKY			10.1164/ajrccm.164.10.2104013
272	Anti–spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection	2-21-2019	JCI Insight	https://doi.org/ggqbpw	https://greenelab.github.io/covid19-review/#ref-tC5vJmwj	https://github.com/greenelab/covid19-review/issues/110	New Paper, Review Needed, immunology, therapeutic, virology	10.1172/jci.insight.123158
273	Changes in Leucocyte Ascorbic Acid during the Common Cold	6-25-2016	Scottish Medical Journal	https://doi.org/ggqrfj	https://greenelab.github.io/covid19-review/#ref-uQFCDDIy			10.1177/003693307301800102
274	What is the role of hydroxychloroquine in reducing thrombotic risk in patients with antiphospholipid antibodies?	12-2-2016	Hematology	https://doi.org/ggrn3k	https://greenelab.github.io/covid19-review/#ref-134vCyU3E			10.1182/asheducation-2016.1.714
275	Mechanism of Action of Hydroxychloroquine in the Antiphospholipid Syndrome	12-2-2016	Blood	https://doi.org/ggrm82	https://greenelab.github.io/covid19-review/#ref-nEaG534R			10.1182/blood.v128.22.5023.5023
276	:{unav)	2005	Virology Journal	https://doi.org/dvbds4	https://greenelab.github.io/covid19-review/#ref-x6nInyCf			10.1186/1743-422x-2-69
277	Development of therapeutic antibodies for the treatment of diseases	1-2-2020	Journal of Biomedical Science	https://doi.org/ggqbpx	https://greenelab.github.io/covid19-review/#ref-1AKi0FYUB			10.1186/s12929-019-0592-z
278	Prognostic factors in the acute respiratory distress syndrome	7-2-2015	Clinical and Translational Medicine	https://doi.org/ggq653	https://greenelab.github.io/covid19-review/#ref-l3CzJ5ni			10.1186/s40169-015-0065-2
279	Efficacy of Zinc Against Common Cold Viruses: An Overview	9-2004	Journal of the American Pharmacists Association	https://doi.org/cf6pmt	https://greenelab.github.io/covid19-review/#ref-sgr0mlJK			10.1331/1544-3191.44.5.594.hulisz
280	Open collaborative writing with Manubot	6-24-2019	PLOS Computational Biology	https://doi.org/c7np	https://greenelab.github.io/covid19-review/#ref-YuJbg3zO			10.1371/journal.pcbi.1007128
281	The Ambiguous Base-Pairing and High Substrate Efficiency of T-705 (Favipiravir) Ribofuranosyl 5′-Triphosphate towards Influenza A Virus Polymerase	7-10-2013	PLoS ONE	https://doi.org/f5br92	https://greenelab.github.io/covid19-review/#ref-ukZRKllk			10.1371/journal.pone.0068347
282	CD147 mediates intrahepatic leukocyte aggregation and determines the extent of liver injury	7-10-2019	PLOS ONE	https://doi.org/ggq654	https://greenelab.github.io/covid19-review/#ref-J0ibHE3l			10.1371/journal.pone.0215557
283	Zn2+ Inhibits Coronavirus and Arterivirus RNA Polymerase Activity In Vitro and Zinc Ionophores Block the Replication of These Viruses in Cell Culture	11-4-2010	PLoS Pathogens	https://doi.org/d95x4g	https://greenelab.github.io/covid19-review/#ref-6aOUJdHa			10.1371/journal.ppat.1001176
284	Efficacy and Safety of All-oral, 12-week Ravidasvir Plus Ritonavir-boosted Danoprevir and Ribavirin in Treatment-naïve Noncirrhotic HCV Genotype 1 Patients: Results from a Phase 2/3 Clinical Trial in China	9-30-2019	Journal of Clinical and Translational Hepatology	https://doi.org/ggrbkd	https://greenelab.github.io/covid19-review/#ref-10GnhBctk			10.14218/jcth.2019.00033
285	Potent human monoclonal antibodies against SARS CoV, Nipah and Hendra viruses	4-8-2009	Expert Opinion on Biological Therapy	https://doi.org/b88kw8	https://greenelab.github.io/covid19-review/#ref-MTcTiS7i			10.1517/14712590902763755
286	Evidence That Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths	3-30-2020		https://doi.org/ggqmjb	https://greenelab.github.io/covid19-review/#ref-yBxajVXZ			10.20944/preprints202003.0235.v2
287	Vitamin B12 May Inhibit RNA-Dependent-RNA Polymerase Activity of nsp12 from the COVID-19 Virus	3-22-2020		https://doi.org/ggqmjc	https://greenelab.github.io/covid19-review/#ref-3RCeQRRc			10.20944/preprints202003.0347.v1
288	SARS-CoV-2 infected host cell proteomics reveal potential therapy targets	3-11-2020		https://doi.org/ggn4ds	https://greenelab.github.io/covid19-review/#ref-CtMA3hTi			10.21203/rs.3.rs-17218/v1
289	Early Transmissibility Assessment of a Novel Coronavirus in Wuhan, China	2020	SSRN Electronic Journal	https://doi.org/ggqhz3	https://greenelab.github.io/covid19-review/#ref-nxM0rP5R			10.2139/ssrn.3524675
290	Longitudinal Characteristics of Lymphocyte Responses and Cytokine Profiles in the Peripheral Blood of SARS-CoV-2 Infected Patients	2020	SSRN Electronic Journal	https://doi.org/ggq655	https://greenelab.github.io/covid19-review/#ref-zskgSnle			10.2139/ssrn.3539682
291	Zinc Lozenges May Shorten the Duration of Colds: A Systematic Review	6-23-2011	The Open Respiratory Medicine Journal	https://doi.org/bndmfq	https://greenelab.github.io/covid19-review/#ref-lPexOhy6			10.2174/1874306401105010051
292	Human neutralizing antibodies against MERS coronavirus: implications for future immunotherapy	7-2015	Immunotherapy	https://doi.org/ggqbpz	https://greenelab.github.io/covid19-review/#ref-pUnzB8wV			10.2217/imt.15.33
293	Vitamin D and the Immune System	12-15-2015	Journal of Investigative Medicine	https://doi.org/f3wh87	https://greenelab.github.io/covid19-review/#ref-n3v9Thlz			10.2310/jim.0b013e31821b8755
294	Interleukin-6; pathogenesis and treatment of autoimmune inflammatory diseases	2013	Inflammation and Regeneration	https://doi.org/ggqmgt	https://greenelab.github.io/covid19-review/#ref-1H8o8TFtM			10.2492/inflammregen.33.054
295	Report 13: Estimating the number of infections and the impact of non-pharmaceutical interventions on COVID-19 in 11 European countries	3-30-2020		https://doi.org/ggrbmf	https://greenelab.github.io/covid19-review/#ref-Frya4XA4	https://github.com/greenelab/covid19-review/issues/170	New Paper, Review Needed, biostatistics, epidemiology	10.25561/77731
296	Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR	1-23-2020	Eurosurveillance	https://doi.org/ggjs7g	https://greenelab.github.io/covid19-review/#ref-1AHtg71LX			10.2807/1560-7917.es.2020.25.3.2000045
297	Hall of Fame among Pro-inflammatory Cytokines: Interleukin-6 Gene and Its Transcriptional Regulation Mechanisms	12-19-2016	Frontiers in Immunology	https://doi.org/ggqmgv	https://greenelab.github.io/covid19-review/#ref-VXDsRwHC			10.3389/fimmu.2016.00604
298	Alveolar Macrophages in the Resolution of Inflammation, Tissue Repair, and Tolerance to Infection	7-31-2018	Frontiers in Immunology	https://doi.org/gd3bnz	https://greenelab.github.io/covid19-review/#ref-9GEyqic3			10.3389/fimmu.2018.01777
299	Influenza A Virus Infection Induces Hyperresponsiveness in Human Lung Tissue-Resident and Peripheral Blood NK Cells	5-17-2019	Frontiers in Immunology	https://doi.org/ggq656	https://greenelab.github.io/covid19-review/#ref-87CJN2CG			10.3389/fimmu.2019.01116
300	Ibalizumab Targeting CD4 Receptors, An Emerging Molecule in HIV Therapy	11-27-2017	Frontiers in Microbiology	https://doi.org/gcn3kh	https://greenelab.github.io/covid19-review/#ref-dUnB3gD6			10.3389/fmicb.2017.02323
301	Airflow as a Possible Transmission Route of Middle East Respiratory Syndrome at an Initial Outbreak Hospital in Korea	12-6-2018	International Journal of Environmental Research and Public Health	https://doi.org/ggqsnk	https://greenelab.github.io/covid19-review/#ref-roLqYkLt			10.3390/ijerph15122757
302	Estimation of the Transmission Risk of the 2019-nCoV and Its Implication for Public Health Interventions	2-7-2020	Journal of Clinical Medicine	https://doi.org/ggmkf4	https://greenelab.github.io/covid19-review/#ref-ITh0Anof			10.3390/jcm9020462
303	Phospholipids of Animal and Marine Origin: Structure, Function, and Anti-Inflammatory Properties	11-14-2017	Molecules	https://doi.org/ggqmgq	https://greenelab.github.io/covid19-review/#ref-E9PuVUHF			10.3390/molecules22111964
304	Vitamin C Can Shorten the Length of Stay in the ICU: A Meta-Analysis	3-27-2019	Nutrients	https://doi.org/gfzscg	https://greenelab.github.io/covid19-review/#ref-DPhRTQw0			10.3390/nu11040708
305	Factors Affecting 25-Hydroxyvitamin D Concentration in Response to Vitamin D Supplementation	6-25-2015	Nutrients	https://doi.org/f7sztz	https://greenelab.github.io/covid19-review/#ref-C3szSqIr			10.3390/nu7075111
306	Vitamin C and Infections	3-29-2017	Nutrients	https://doi.org/gfkb9n	https://greenelab.github.io/covid19-review/#ref-aEEZ8Pq9			10.3390/nu9040339
307	Vitamin C and Immune Function	11-3-2017	Nutrients	https://doi.org/gfzrjs	https://greenelab.github.io/covid19-review/#ref-13M3VAfY9			10.3390/nu9111211
308	Neutralizing Monoclonal Antibodies as Promising Therapeutics against Middle East Respiratory Syndrome Coronavirus Infection	11-30-2018	Viruses	https://doi.org/ggp87v	https://greenelab.github.io/covid19-review/#ref-181QWa7HL			10.3390/v10120680
309	A pilot study of hydroxychloroquine in treatment of patients with common coronavirus disease-19 (COVID-19)	3-2020	Journal of Zhejiang University (Medical Sciences)	https://doi.org/10.3785/j.issn.1008-9292.2020.03.03	https://greenelab.github.io/covid19-review/#ref-o5gwQA7W	https://github.com/greenelab/covid19-review/issues/126	New Paper, Review Needed, biostatistics, therapeutic	10.3785/j.issn.1008-9292.2020.03.03
310	Fish Oil-Fed Mice Have Impaired Resistance to Influenza Infection	8-2009	The Journal of Nutrition	https://doi.org/dv45f4	https://greenelab.github.io/covid19-review/#ref-B8toe6Mr			10.3945/jn.109.108027
311	Zinc-Dependent Suppression of TNF-α Production Is Mediated by Protein Kinase A-Induced Inhibition of Raf-1, IκB Kinase β, and NF-κB	9-15-2007	The Journal of Immunology	https://doi.org/f3vs45	https://greenelab.github.io/covid19-review/#ref-Qif5U0Ig			10.4049/jimmunol.179.6.4180
312	Tolerability of intramuscular and intradermal delivery by CELLECTRA <sup>®</sup> adaptive constant current electroporation device in healthy volunteers	10-27-2014	Human Vaccines & Immunotherapeutics	https://doi.org/ggrj7h	https://greenelab.github.io/covid19-review/#ref-1Hsm2J1sc			10.4161/hv.24702
313	Using the MAARIE Framework To Read the Research Literature	7-1-2006	American Journal of Occupational Therapy	https://doi.org/bqh97x	https://greenelab.github.io/covid19-review/#ref-17OQtAY4l			10.5014/ajot.60.4.367
314	Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies	2020	BioScience Trends	https://doi.org/ggm3mv	https://greenelab.github.io/covid19-review/#ref-aiItPxSY			10.5582/bst.2020.01047
315	SARS-CoV-2: an Emerging Coronavirus that Causes a Global Threat	2020	International Journal of Biological Sciences	https://doi.org/ggqspr	https://greenelab.github.io/covid19-review/#ref-z8XnLYWM			10.7150/ijbs.45053
316	Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19	2020	International Journal of Biological Sciences	https://doi.org/ggqspm	https://greenelab.github.io/covid19-review/#ref-1BdQKtXnY			10.7150/ijbs.45498
317	Clinical Course and Outcomes of Critically Ill Patients With Middle East Respiratory Syndrome Coronavirus Infection	3-18-2014	Annals of Internal Medicine	https://doi.org/ggptxw	https://greenelab.github.io/covid19-review/#ref-iObQU2el			10.7326/m13-2486
318	Induction of cell cycle arrest and B cell terminal differentiation by CDK inhibitor p18(INK4c) and IL-6.	1-1997	Immunity	https://www.ncbi.nlm.nih.gov/pubmed/9052836	https://greenelab.github.io/covid19-review/#ref-1AVsj9DAP			10.1016/s1074-7613(00)80241-1
319						https://github.com/greenelab/covid19-review/issues/195	New Paper, Review Needed, immunology, virology	10.1101/2020.04.09.033522]
320						https://github.com/greenelab/covid19-review/issues/194	New Paper, Review Needed, immunology, virology	10.1101/2020.03.31.019216]
321						https://github.com/greenelab/covid19-review/issues/191	New Paper, Review Needed, epidemiology	10.1101/2020.04.05.20054502
322						https://github.com/greenelab/covid19-review/issues/189	New Paper, Review Needed, biostatistics, pharmacology, therapeutic	10.1101/2020.04.08.20054551
323						https://github.com/greenelab/covid19-review/issues/186	New Paper, Review Needed, biostatistics, pharmacology, therapeutic	10.1056/nejmoa2007016
324						https://github.com/greenelab/covid19-review/issues/185	New Paper, Review Needed, diagnostic	10.1101/2020.03.23.20041889
325						https://github.com/greenelab/covid19-review/issues/184	New Paper, Review Needed, diagnostic	10.1038/s41586-020-2196-x
326						https://github.com/greenelab/covid19-review/issues/177	New Paper, Review Needed	10.1001/jamaoto.2020.0832
327						https://github.com/greenelab/covid19-review/issues/168	New Paper, Review Needed, therapeutic	10.1126/scitranslmed.aac7462
328						https://github.com/greenelab/covid19-review/issues/167	New Paper, Review Needed, therapeutic	10.1038/nrmicro2147
329						https://github.com/greenelab/covid19-review/issues/166	New Paper, Review Needed, immunology, virology	10.1016/j.antiviral.2020.104742
330						https://github.com/greenelab/covid19-review/issues/145	New Paper, Review Needed, therapeutic	10.1016/j.cell.2020.04.004
331						https://github.com/greenelab/covid19-review/issues/143	Additional Reviews Welcome, New Paper, biostatistics, epidemiology	10/ggnxb3
332						https://github.com/greenelab/covid19-review/issues/137	New Paper, Review Needed, immunology, pharmacology, virology	10.1016/j.cell.2020.02.052]
333						https://github.com/greenelab/covid19-review/issues/134	New Paper, Review Needed, therapeutic	10.1101/2020.03.23.20039362
334						https://github.com/greenelab/covid19-review/issues/133	New Paper, Review Needed, biostatistics, immunology, virology	10.1101/2020.03.30.016931
335						https://github.com/greenelab/covid19-review/issues/129	New Paper, Review Needed, therapeutic	10.1101/2020.03.28.20045955
336						https://github.com/greenelab/covid19-review/issues/128	New Paper, Review Needed, therapeutic	10.1101/2020.03.19.20038984
337						https://github.com/greenelab/covid19-review/issues/127	New Paper, Review Needed, therapeutic	10.1101/2020.03.19.20039008
338						https://github.com/greenelab/covid19-review/issues/118	New Paper, Review Needed	10.1101/2020.03.27.009480v1
339						https://github.com/greenelab/covid19-review/issues/117	New Paper, Review Needed, diagnostic	10.1101/2020.03.26.20039438
340						https://github.com/greenelab/covid19-review/issues/114	New Paper, Review Needed, biostatistics, epidemiology	10.25561/77482]
341						https://github.com/greenelab/covid19-review/issues/108	New Paper, Review Needed	10.1038/s41586-020-2008-3]
342						https://github.com/greenelab/covid19-review/issues/107	New Paper, Review Needed	10.1101/2020.02.19.950253]
343						https://github.com/greenelab/covid19-review/issues/106	New Paper, Review Needed	10.1038/s41586-020-2012-7]
344						https://github.com/greenelab/covid19-review/issues/105	New Paper, Review Needed, immunology	10.1101/2020.02.23.20026690]
345						https://github.com/greenelab/covid19-review/issues/104	New Paper, Review Needed, epidemiology, virology	10.1056/nejmc2004973
346						https://github.com/greenelab/covid19-review/issues/103	New Paper, Review Needed, epidemiology	10.1126/science.abb3221]
347						https://github.com/greenelab/covid19-review/issues/98	New Paper, Review Needed, pharmacology, therapeutic	10.1021/acscentsci.0c00272
348						https://github.com/greenelab/covid19-review/issues/97	Additional Reviews Welcome, New Paper	10.1101/2020.03.21.990770v2
349						https://github.com/greenelab/covid19-review/issues/91	New Paper, Review Needed	10.1101/2020.02.10.942748
350						https://github.com/greenelab/covid19-review/issues/85	New Paper, Review Needed	10/ggjr43]
351						https://github.com/greenelab/covid19-review/issues/71	Additional Reviews Welcome, New Paper, pharmacology, therapeutic, virology	10.1056/nejmoa2001282
352						https://github.com/greenelab/covid19-review/issues/56	New Paper, Review Needed, immunology, pharmacology, therapeutic, virology	10.1016/j.drudis.2019.01.018
